Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 126

Similar articles for PubMed (Select 14742753)

1.

Tracking trends in secondary stroke prevention strategies.

Carswell JL, Beard KA, Chevrette MM, Pardue CN, Hess DC, Fagan SC.

Ann Pharmacother. 2004 Feb;38(2):215-9. Epub 2003 Dec 23.

PMID:
14742753
2.

Compliance with secondary prevention of ischemic stroke: a prospective evaluation.

Sappok T, Faulstich A, Stuckert E, Kruck H, Marx P, Koennecke HC.

Stroke. 2001 Aug;32(8):1884-9.

3.

New perspectives on the pharmacotherapy of ischemic stroke.

Bradberry JC, Fagan SC, Gray DR, Moon YS.

J Am Pharm Assoc (2003). 2004 Mar-Apr;44(2 Suppl 1):S46-56; quiz S56-7. Review.

PMID:
15095935
4.

Use of medications for secondary prevention in stroke patients at hospital discharge in Australia.

Eissa A, Krass I, Bajorek BV.

Int J Clin Pharm. 2014 Apr;36(2):384-93. doi: 10.1007/s11096-013-9908-3. Epub 2014 Feb 12.

PMID:
24519632
5.

The emergency department: first line of defense in preventing secondary stroke.

Ovbiagele B.

Acad Emerg Med. 2006 Feb;13(2):215-22. Epub 2006 Jan 25.

6.

Secondary prevention of stroke: a practical guide to drug treatment.

Koennecke HC.

CNS Drugs. 2004;18(4):221-41. Review.

PMID:
15015903
7.

Secondary prevention after ischemic stroke. Evolution over time in practice.

Girot M, Mackowiak-Cordoliani MA, Deplanque D, Hénon H, Lucas C, Leys D.

J Neurol. 2005 Jan;252(1):14-20.

PMID:
15654550
8.

[Secondary stroke and its prevention in patients with arterial hypertension].

Parfenov VA, Gurak SV.

Zh Nevrol Psikhiatr Im S S Korsakova. 2005;(Suppl 14):3-7. Russian.

PMID:
16184847
9.
10.

Use of antihypertensive and antithrombotic medications after stroke in community-based care.

Rigler SK, Webb MJ, Patel AT, Lai SM, Duncan PW.

Ann Pharmacother. 2001 Jul-Aug;35(7-8):811-6.

PMID:
11485125
11.

The prescribing patterns of antithrombotic agents for prevention of recurrent ischemic stroke.

Po HL, Lin YJ, Hseuh IH.

Acta Neurol Taiwan. 2009 Jun;18(2):98-103.

PMID:
19673361
12.

PROTECT: a coordinated stroke treatment program to prevent recurrent thromboembolic events.

Ovbiagele B, Saver JL, Fredieu A, Suzuki S, McNair N, Dandekar A, Razinia T, Kidwell CS.

Neurology. 2004 Oct 12;63(7):1217-22.

PMID:
15477541
13.

Secondary stroke prevention: practice patterns in a tertiary care stroke service.

Fan JC, Mysak TM, Jeerakathil TJ, Pearson GJ.

Can J Neurol Sci. 2010 Mar;37(2):245-51.

PMID:
20437937
14.

The need for wider and appropriate utilization of aspirin and statins in the treatment and prevention of cardiovascular disease.

Hennekens CH, Schneider WR.

Expert Rev Cardiovasc Ther. 2008 Jan;6(1):95-107. Review.

PMID:
18095910
15.
16.

Medication persistence rates and factors associated with persistence in patients following stroke: a cohort study.

Lummis HL, Sketris IS, Gubitz GJ, Joffres MR, Flowerdew GJ.

BMC Neurol. 2008 Jul 10;8:25. doi: 10.1186/1471-2377-8-25.

17.

Antithrombotic and antihypertensive management 3 months after ischemic stroke : a prospective study in an inner city population.

Hillen T, Dundas R, Lawrence E, Stewart JA, Rudd AG, Wolfe CD.

Stroke. 2000 Feb;31(2):469-75.

18.

Secondary-prevention drug prescription in the very elderly after ischemic stroke or TIA.

Ovbiagele B, Hills NK, Saver JL, Johnston SC.

Neurology. 2006 Feb 14;66(3):313-8.

PMID:
16476928
19.

Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice.

Vermeer NS, Bajorek BV.

J Clin Pharm Ther. 2008 Dec;33(6):591-601. doi: 10.1111/j.1365-2710.2008.00950.x.

PMID:
19138236
20.

The association of race and sex with the underuse of stroke prevention measures.

Tuhrim S, Cooperman A, Rojas M, Brust JC, Koppel B, Martin K, Chassin M.

J Stroke Cerebrovasc Dis. 2008 Jul-Aug;17(4):226-34. doi: 10.1016/j.jstrokecerebrovasdis.2008.02.003.

PMID:
18589344
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk